Hemlibra
Hemlibra ingredients
| Active ingredient | Strength |
|---|---|
| Emicizumab | 60 mg/.4mL, 30 mg/mL, 150 mg/mL, 300 mg/2mL, 105 mg/.7mL, 12 mg/.4mL |
What Hemlibra is used for
Hemlibra is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Hemlibra
- Generic name
- Emicizumab
- Made by
- Genentech, Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA761083
- On the US market since
- 2017
Official information
- Hemlibra prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Emicizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Hemlibra?
Hemlibra (Emicizumab) is a specialist medicine made by Genentech, Inc., approved by the US FDA.
What are the ingredients of Hemlibra?
Hemlibra contains Emicizumab (60 mg/.4mL, 30 mg/mL, 150 mg/mL, 300 mg/2mL, 105 mg/.7mL, 12 mg/.4mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA